DEL (DNA Encoded Compound Library) Primers
Description
The concept of DNA Encoded Compound Library (DEL) synthesis and screening was introduced in 1992 by Sydney Brenner and Richard Lerner from The Scripps Research Institute. DEL technology has revolutionized drug discovery by making lead compound screening faster and more efficient, sparking a new wave in drug development.
Our DEL primer synthesis platform is dedicated to fully meeting the quality requirements for primers used in DNA encoded compound library construction for small molecule drug discovery. With a team of experts who have accumulated years of experience in primer synthesis, we track your project progress closely to save you time and labor costs in pre-library construction quality control.
Advantages
- High Throughput and Large-Scale Synthesis: Meets various library construction needs.
- Automated Pipetting Workstations and Enzyme Labeling: Ensures accurate quantification.
- Strict QC Measures: LC-MS testing for each primer to ensure sequence accuracy.
- Fast Delivery: 10 days for 10,000 DEL tags (1 μmol/tag).
- Standardized DNA Synthesis Process: Minimal batch-to-batch variation and stable quality.
- Dedicated Delivery: Avoids contamination or damage during shipping.
SBS Genetech is recognized as one of the global major leading industry players in Oligonucleotide Synthesis by third-party market researchers. For more details, please visit Oligonucleotide Synthesis Services Market landscape, Top Competitor Analysis, Revenue, Sales With Forecast Data from 2022 to 2028.
